Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics Statistics

Total Valuation

PLRX has a market cap or net worth of $71.20 million. The enterprise value is -$69.67 million.

Market Cap	71.20M
Enterprise Value	-69.67M

Important Dates

The last earnings date was Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

PLRX has 61.91 million shares outstanding. The number of shares has increased by 1.17% in one year.

Current Share Class	61.91M
Shares Outstanding	61.91M
Shares Change (YoY)	+1.17%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	2.73%
Owned by Institutions (%)	77.65%
Float	60.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.44
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.89, with a Debt / Equity ratio of 0.17.

Current Ratio	16.89
Quick Ratio	16.50
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-44.12

Financial Efficiency

Return on equity (ROE) is -53.62% and return on invested capital (ROIC) is -27.60%.

Return on Equity (ROE)	-53.62%
Return on Assets (ROA)	-25.78%
Return on Invested Capital (ROIC)	-27.60%
Return on Capital Employed (ROCE)	-58.73%
Weighted Average Cost of Capital (WACC)	9.79%
Revenue Per Employee	n/a
Profits Per Employee	-$2.31M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.44% in the last 52 weeks. The beta is 1.21, so PLRX's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-15.44%
50-Day Moving Average	1.27
200-Day Moving Average	1.41
Relative Strength Index (RSI)	34.00
Average Volume (20 Days)	497,101

Short Selling Information

The latest short interest is 3.64 million, so 5.88% of the outstanding shares have been sold short.

Short Interest	3.64M
Short Previous Month	4.03M
Short % of Shares Out	5.88%
Short % of Float	6.04%
Short Ratio (days to cover)	7.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-112.91M
Pretax Income	-113.22M
Net Income	-113.22M
EBITDA	-111.40M
EBIT	-112.91M
Earnings Per Share (EPS)	-$1.84

Balance Sheet

The company has $170.89 million in cash and $28.78 million in debt, with a net cash position of $142.11 million or $2.30 per share.

Cash & Cash Equivalents	170.89M
Total Debt	28.78M
Net Cash	142.11M
Net Cash Per Share	$2.30
Equity (Book Value)	165.17M
Book Value Per Share	2.67
Working Capital	164.57M

Cash Flow

In the last 12 months, operating cash flow was -$98.70 million and capital expenditures -$112,000, giving a free cash flow of -$98.81 million.

Operating Cash Flow	-98.70M
Capital Expenditures	-112,000
Depreciation & Amortization	1.51M
Net Borrowing	-32.27M
Free Cash Flow	-98.81M
FCF Per Share	-$1.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.17%
Shareholder Yield	-1.17%
Earnings Yield	-156.29%
FCF Yield	-136.41%

Analyst Forecast

The average price target for PLRX is $2.67, which is 132.17% higher than the current price. The consensus rating is "Hold".

Price Target	$2.67
Price Target Difference	132.17%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-19.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2